Recro Pharma, Inc.
Recro Pharma, Inc. (REPH) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 359 transactions totaling $42.0M, demonstrating a bearish sentiment with -$10.9M in net insider flow. The most recent transaction on Mar 15, 2022 involved a purchase of 512 shares valued at $1.0K.
REPH Insider Activity Summary
Who Is Buying REPH Stock?
No significant insider buying has been recorded for REPH in the recent period.
Who Is Selling REPH Stock?
No significant insider selling has been recorded for REPH in the recent period.
Is Recro Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for REPH is bearish with an Insider Alignment Score of 37/100 and a net flow of -$10.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
REPH Frequently Asked Questions
Understanding REPH Insider Activity
Insider trading at Recro Pharma, Inc. (REPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading REPH stock, having executed 359 transactions in the past 90 days. The most active insider is Capital, Llc Broadfin (Executive), who has made 21 transactions totaling $12.7M.
Related Tools
Track Recro Pharma, Inc. Insider Activity
Get notified when executives and directors at REPH file new Form 4 transactions